262 related articles for article (PubMed ID: 23788045)
1. Immunogenic tumor cell death induced by chemoradiotherapy: molecular mechanisms and a clinical translation.
Kono K; Mimura K; Kiessling R
Cell Death Dis; 2013 Jun; 4(6):e688. PubMed ID: 23788045
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic cancer cell death: a key-lock paradigm.
Tesniere A; Apetoh L; Ghiringhelli F; Joza N; Panaretakis T; Kepp O; Schlemmer F; Zitvogel L; Kroemer G
Curr Opin Immunol; 2008 Oct; 20(5):504-11. PubMed ID: 18573340
[TBL] [Abstract][Full Text] [Related]
3. Cell death induced by cytotoxic CD8
Jaime-Sanchez P; Uranga-Murillo I; Aguilo N; Khouili SC; Arias MA; Sancho D; Pardo J
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32241808
[TBL] [Abstract][Full Text] [Related]
4. Tumor cell lysates as immunogenic sources for cancer vaccine design.
González FE; Gleisner A; Falcón-Beas F; Osorio F; López MN; Salazar-Onfray F
Hum Vaccin Immunother; 2014; 10(11):3261-9. PubMed ID: 25625929
[TBL] [Abstract][Full Text] [Related]
5. Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Suzuki Y; Mimura K; Yoshimoto Y; Watanabe M; Ohkubo Y; Izawa S; Murata K; Fujii H; Nakano T; Kono K
Cancer Res; 2012 Aug; 72(16):3967-76. PubMed ID: 22700877
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity.
Ogawa M; Tomita Y; Nakamura Y; Lee MJ; Lee S; Tomita S; Nagaya T; Sato K; Yamauchi T; Iwai H; Kumar A; Haystead T; Shroff H; Choyke PL; Trepel JB; Kobayashi H
Oncotarget; 2017 Feb; 8(6):10425-10436. PubMed ID: 28060726
[TBL] [Abstract][Full Text] [Related]
7. Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists.
Yamazaki T; Hannani D; Poirier-Colame V; Ladoire S; Locher C; Sistigu A; Prada N; Adjemian S; Catani JP; Freudenberg M; Galanos C; André F; Kroemer G; Zitvogel L
Cell Death Differ; 2014 Jan; 21(1):69-78. PubMed ID: 23811849
[TBL] [Abstract][Full Text] [Related]
8. Cross-Presentation of the Oncofetal Tumor Antigen 5T4 from Irradiated Prostate Cancer Cells--A Key Role for Heat-Shock Protein 70 and Receptor CD91.
Salimu J; Spary LK; Al-Taei S; Clayton A; Mason MD; Staffurth J; Tabi Z
Cancer Immunol Res; 2015 Jun; 3(6):678-88. PubMed ID: 25678582
[TBL] [Abstract][Full Text] [Related]
9. Killer dendritic cells: IKDC and the others.
Bonmort M; Dalod M; Mignot G; Ullrich E; Chaput N; Zitvogel L
Curr Opin Immunol; 2008 Oct; 20(5):558-65. PubMed ID: 18554881
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and cancer: a double-edged sword.
Hagemann T; Balkwill F; Lawrence T
Cancer Cell; 2007 Oct; 12(4):300-1. PubMed ID: 17936555
[TBL] [Abstract][Full Text] [Related]
11. Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy.
Wang Y; Xie W; Humeau J; Chen G; Liu P; Pol J; Zhang Z; Kepp O; Kroemer G
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221018
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference.
Chaput N; De Botton S; Obeid M; Apetoh L; Ghiringhelli F; Panaretakis T; Flament C; Zitvogel L; Kroemer G
J Mol Med (Berl); 2007 Oct; 85(10):1069-76. PubMed ID: 17891368
[TBL] [Abstract][Full Text] [Related]
13. Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing.
Gameiro SR; Jammeh ML; Wattenberg MM; Tsang KY; Ferrone S; Hodge JW
Oncotarget; 2014 Jan; 5(2):403-16. PubMed ID: 24480782
[TBL] [Abstract][Full Text] [Related]
14. Immunogenic tumor cell death induced by chemotherapy in patients with breast cancer and esophageal squamous cell carcinoma.
Aoto K; Mimura K; Okayama H; Saito M; Chida S; Noda M; Nakajima T; Saito K; Abe N; Ohki S; Ohtake T; Takenoshita S; Kono K
Oncol Rep; 2018 Jan; 39(1):151-159. PubMed ID: 29138861
[TBL] [Abstract][Full Text] [Related]
15. Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment.
Chang MC; Chen YL; Lin HW; Chiang YC; Chang CF; Hsieh SF; Chen CA; Sun WZ; Cheng WF
Mol Ther; 2018 Feb; 26(2):404-419. PubMed ID: 29248428
[TBL] [Abstract][Full Text] [Related]
16. Many faces of DAMPs in cancer therapy.
Krysko O; Løve Aaes T; Bachert C; Vandenabeele P; Krysko DV
Cell Death Dis; 2013 May; 4(5):e631. PubMed ID: 23681226
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic anti-cancer chemotherapy as an emerging concept.
Haynes NM; van der Most RG; Lake RA; Smyth MJ
Curr Opin Immunol; 2008 Oct; 20(5):545-57. PubMed ID: 18573339
[TBL] [Abstract][Full Text] [Related]
18. Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.
Zappasodi R; Pupa SM; Ghedini GC; Bongarzone I; Magni M; Cabras AD; Colombo MP; Carlo-Stella C; Gianni AM; Di Nicola M
Cancer Res; 2010 Nov; 70(22):9062-72. PubMed ID: 20884630
[TBL] [Abstract][Full Text] [Related]
19. Human tumor cells killed by anthracyclines induce a tumor-specific immune response.
Fucikova J; Kralikova P; Fialova A; Brtnicky T; Rob L; Bartunkova J; Spísek R
Cancer Res; 2011 Jul; 71(14):4821-33. PubMed ID: 21602432
[TBL] [Abstract][Full Text] [Related]
20. Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells.
Aguilera R; Saffie C; Tittarelli A; González FE; Ramírez M; Reyes D; Pereda C; Hevia D; García T; Salazar L; Ferreira A; Hermoso M; Mendoza-Naranjo A; Ferrada C; Garrido P; López MN; Salazar-Onfray F
Clin Cancer Res; 2011 Apr; 17(8):2474-83. PubMed ID: 21292818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
